ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma

Bao, Ji-Ming*; Zhi, Xi; Yuan, Hao-Yu; Chen, Tao-Yi; Chen, Ming-Kun; Zhou, Jun-Hao; Xue, Kang-Yi; Yang, Jian-Kun*; Liu, Cun-Dong*南方医科大学; jk
Translational Cancer Research2023-3DOI: 10.21037/tcr-22-417
3阅读
引用收藏
分享

摘要

Background: Sphingosine kinase 1 (SPHK1) is a key enzyme that catalyzes the phosphorylation of sphingosine. Recent studies reported SPHK1 to be associated with renal cell carcinoma (RCC) progression by inducing targeted therapy resistance. However, the expression and the clinical significance of SPHK1 on RCC in those having received targeted therapy have not been elucidated. The present study explored the expression of SPHK1 in RCC tissues from targeted therapy recipients, the correlation of SPHK1 with clinicopathological parameters, and the effect of SPHK1 on RCC patient prognosis. @@@ Methods: Differential gene expression analysis of RCC treated with and without targeted therapy was performed. The correlations of SPHK1 expression with clinical parameters of RCC were examined. Gene set enrichment analysis (GSEA) was performed to clarify the potential role of SPHK1 associated with targeted therapy resistance. The value of SPHK1 as a diagnostic marker for RCC was also evaluated. The Kaplan-Meier method was applied to analyze the correlation between SPHK1 expression and patient survival rate by using the clinical data from patients with RCC. @@@ Results: Significant overexpression of SPHK1 was detected in RCC treated with targeted therapy. SPHK1 expression was closely correlated with RCC progression-related clinicopathological parameters. Therefore, elevated SPHK1 could effectively diagnose RCC and distinguish RCC with an advanced clinical stage and a high pathological grade. SPHK1 was associated with the stemness of RCC cells via the activation of the Wnt, Hedgehog, or Notch signaling pathways in targeted drug-treated or untreated RCC. Survival analysis of a large cohort of RCC samples indicated overexpression of SPHK1 to be inversely correlated with the overall and disease-free survival of patients with RCC. @@@ Conclusions: Our study indicated that SPHK1 associated with targeted therapy resistance could serve as a potential prognostic marker and a valuable biomarker of response to angiogenic agents in RCC.

学科与关键词

关键词
Renal cell carcinoma (RCC)sphingosine kinase 1 (SPHK1)targeted therapy resistanceprognosis
相关
加载中…
  • Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy
    Liu Guanglin; Zheng Haiqing; Zhang Zhibing; Wu Zhiqiang; Xiong Huaping; Li Jun; Song Libing*BMC Cancer, 2010, 10: 495.被引 22
  • SPARC is a key mediator of TGF-β-induced renal cancer metastasis
    Bao, Ji-Ming; Dang, Qiang; Lin, Chun-Jung; Lo, U-Ging; Feldkoren, Boris; Dang, Andrew; Hernandez, Elizabeth; Li, Fei; Panwar, Vandana; Lee, Cheng-Fan; Cen, Jun-Jie; Guan, Bing; Margulis, Vitaly; Kapur, Payal; Brekken, Rolf A.; Luo, Jun-Hang*; Hsieh, Jer-Tsong*; Tan, Wan-Long*Journal of Cellular Physiology, 2021, 236(3): 1926-1938.被引 27
  • Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-kappa B Pathway in Human Non-Small Cell Lung Cancer
    Song Libing*; Xiong Huaping; Li Jun; Liao Wenting; Wang Lan; Wu Jueheng; Li MengfengClinical Cancer Research, 2011, 17(7): 1839-1849.被引 62
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Cancer Research
发表日期
2023-03
卷期
第 12 卷, 第 3 期
页码
572-584
DOI
10.21037/tcr-22-417
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82002690]; Guangdong Basic and Applied Basic Research Foundation [2022A1515010096]; Medical Scientific Research Foundation of Guangdong Province [A2019513, A2020230]; Science and Technology Planning Project of Guangzhou [202102021108]; Southern Medical University [LX2018N001]; Third Affiliated Hospital of Southern Medical University [2019Q008]

作者

  • B

    Bao, Ji-Ming (通讯) (第一作者)

    southern med univ

  • Z

    Zhi, Xi

查看全部 9 位作者收起作者
  • Y

    Yuan, Hao-Yu

    southern med univ

  • C

    Chen, Tao-Yi

    southern med univ

  • C

    Chen, Ming-Kun

    southern med univ

  • Z

    Zhou, Jun-Hao

    southern med univ

  • X

    Xue, Kang-Yi

    southern med univ

  • Y

    Yang, Jian-Kun (通讯)

    southern med univ

  • L

    Liu, Cun-Dong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417